Brufsky AM - Search Results

1

Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.

Koleck TA, Bender CM, Sereika SM, Ryan CM, Ghotkar P, Brufsky AM, Jankowitz RC, McAuliffe PF, Clark BZ, Conley YP. Koleck TA, et al. Among authors: brufsky am. Cancer Med. 2017 Feb;6(2):339-348. doi: 10.1002/cam4.964. Epub 2017 Jan 13. Cancer Med. 2017. PMID: 28083945 Free PMC article.

2

The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events.

Rosenzweig MQ, Bender CM, Lucke JP, Yasko JM, Brufsky AM. Rosenzweig MQ, et al. Among authors: brufsky am. J Pain Symptom Manage. 2004 Feb;27(2):185-90. doi: 10.1016/j.jpainsymman.2003.06.010. J Pain Symptom Manage. 2004. PMID: 15157043 Free article. Clinical Trial.

3

The nurse as principal investigator in a pharmaceutically sponsored drug trial: considerations and challenges.

Rosenzweig MQ, Bender CM, Brufsky AM. Rosenzweig MQ, et al. Among authors: brufsky am. Oncol Nurs Forum. 2005 Mar 5;32(2):293-9. doi: 10.1188/05.ONF.293-299. Oncol Nurs Forum. 2005. PMID: 15759067

4

Cognitive impairment associated with adjuvant therapy in breast cancer.

Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM. Bender CM, et al. Among authors: brufsky am. Psychooncology. 2006 May;15(5):422-30. doi: 10.1002/pon.964. Psychooncology. 2006. PMID: 16097037

5

Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer.

Brufsky A, Lembersky B, Schiffman K, Lieberman G, Paton VE. Brufsky A, et al. Clin Breast Cancer. 2005 Aug;6(3):247-52. doi: 10.3816/CBC.2005.n.027. Clin Breast Cancer. 2005. PMID: 16137436

6

Single-fraction radiosurgery for the treatment of spinal breast metastases.

Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, Vogel WJ. Gerszten PC, et al. Among authors: brufsky am. Cancer. 2005 Nov 15;104(10):2244-54. doi: 10.1002/cncr.21467. Cancer. 2005. PMID: 16216003 Free article.

7

Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial.

Greenspan SL, Bhattacharya RK, Sereika SM, Brufsky A, Vogel VG. Greenspan SL, et al. J Clin Endocrinol Metab. 2007 Jan;92(1):131-6. doi: 10.1210/jc.2006-1272. Epub 2006 Oct 17. J Clin Endocrinol Metab. 2007. PMID: 17047022 Clinical Trial.

8

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL. Bender CM, et al. Among authors: brufsky am. Menopause. 2007 Nov-Dec;14(6):995-8. doi: 10.1097/gme.0b013e318148b28b. Menopause. 2007. PMID: 17898668 Free PMC article.

9

Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors.

Brufsky AM. Brufsky AM. Clin Breast Cancer. 2007 Dec;8 Suppl 1:S22-34. doi: 10.3816/cbc.2007.s.009. Clin Breast Cancer. 2007. PMID: 18282367 Review.

10

Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.

Greenspan SL, Brufsky A, Lembersky BC, Bhattacharya R, Vujevich KT, Perera S, Sereika SM, Vogel VG. Greenspan SL, et al. J Clin Oncol. 2008 Jun 1;26(16):2644-52. doi: 10.1200/JCO.2007.15.2967. Epub 2008 Apr 21. J Clin Oncol. 2008. PMID: 18427147 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters